Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Antibiotics > Cefotaxime sodium for Sale > Wholesale good High Quality Pharmaceutical Material Antibiotic Drug CAS 64485-93-4 99% Purity API Powder Sterile Cefotaxime Sodium with Best Price
Wholesale good High Quality Pharmaceutical Material Antibiotic Drug CAS 64485-93-4 99% Purity API Powder Sterile Cefotaxime Sodium with Best Price buy - large image1
Wholesale good High Quality Pharmaceutical Material Antibiotic Drug CAS 64485-93-4 99% Purity API Powder Sterile Cefotaxime Sodium with Best Price buy - image1
Wholesale good High Quality Pharmaceutical Material Antibiotic Drug CAS 64485-93-4 99% Purity API Powder Sterile Cefotaxime Sodium with Best Price buy - image2
Wholesale good High Quality Pharmaceutical Material Antibiotic Drug CAS 64485-93-4 99% Purity API Powder Sterile Cefotaxime Sodium with Best Price buy - image3
Wholesale good High Quality Pharmaceutical Material Antibiotic Drug CAS 64485-93-4 99% Purity API Powder Sterile Cefotaxime Sodium with Best Price buy - image4
Wholesale good High Quality Pharmaceutical Material Antibiotic Drug CAS 64485-93-4 99% Purity API Powder Sterile Cefotaxime Sodium with Best Price buy - image5
Wholesale good High Quality Pharmaceutical Material Antibiotic Drug CAS 64485-93-4 99% Purity API Powder Sterile Cefotaxime Sodium with Best Price buy - image6

Wholesale good High Quality Pharmaceutical Material Antibiotic Drug CAS 64485-93-4 99% Purity API Powder Sterile Cefotaxime Sodium with Best Price

TDS 3 Inquiries

Unit Price:

$80/KG FOB

Get Latest Price
CAS No.:

64485-93-4

Grade:

Food Grade

Content:

99%

Port:

shanghai

Brand:

wanwei

Packaging:

25kg/Drum

Price valid (until):

2028-03-31

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Tirzepatide,Retatrutide,Semaglutide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Cefotaxime sodium is a third-generation semi-synthetic cephalosporin. It is not as effective against Gram-positive bacteria as cefazolin. Enterococcus is resistant to this product. It is not effective against penicillin-resistant pneumococci. It has a strong effect on Gram-negative bacteria. Bactericidal activity, antibacterial effect against Escherichia coli, influenza bacillus, Klebsiella pneumoniae, Proteus mirabilis, Salmonella is stronger than cefoperazone, weak or resistant to Bacteroides fragilis, Pseudomonas aeruginosa, Enterobacter cloacae Product is not sensitive.

    Cefotaxime is widely distributed in various tissues and body fluids throughout the body. The concentration of the drug in normal cerebrospinal fluid is very low; after application of this product in meningitis patients, the effective concentration can be reached in the cerebrospinal fluid. Bronchial secretions, middle ear discharge, pleural effusion, empyema, ascites, gallbladder wall, bile, bone tissue can also reach effective concentration: this product can enter the fetal blood circulation through the placental barrier, a small amount can also Enter the milk.

    Cefotaxime sodium is used for infection of respiratory tract, urinary tract, bones and joints, skin and soft tissues, abdominal cavity, biliary tract, digestive tract, facial features, genitals, etc. caused by sensitive bacteria, infection caused by burns and trauma, and sepsis, central The infection is also effective.

    Items Specifications
    Product name Cefotaxime sodium
    CAS No. 64485-93-4
    MF C16H18N5NaO7S2
    MW 479.46
    EINECS No. 264-915-9
    Melting point 162-163 C
    Boiling point N/A
    Density N/A
    Storage Keep in dark place,Inert atmosphere,2-8°C
    Solubility H2O: aqueous solutions of pH 4.3-6.2 are stable up to 3 weeks at 2-8 °C.soluble


      Detailed Photos  


    Shop Wholesale good High Quality Pharmaceutical Material Antibiotic Drug CAS 64485-93-4 99% Purity API Powder Sterile Cefotaxime Sodium with Best Price-Detailed Image 1 Shop Wholesale good High Quality Pharmaceutical Material Antibiotic Drug CAS 64485-93-4 99% Purity API Powder Sterile Cefotaxime Sodium with Best Price-Detailed Image 2


      Company Profile  


    Changsha Wanwei, headquartered in Changsha, China, is aiming to be a global player in chemical trading and integrated solutions.

    Specializing in Pharmaceutical intermediates, Agrochemical intermediates, Fine chemicals, Herbal extracts and Cosmetic ingredients, we deliver end-to-end services spanning sourcing, supply chain optimization, customized synthesis, cost management, and quality assurance, with all stage support from sample, pilot, registration and commercial

    Our mission is to empower clients worldwide with agile, sustainable, and value-driven partnerships in the ever-evolving chemical industry.

    Competitive Advantages
    Expert Team: International team of chemical engineers, trading specialists and supply chain professionals
    Quality Commitment: Rigorous supplier selection and ISO-certified quality management systems
    Sustainable Development: Partnering with eco-friendly manufacturers to promote green chemistry
    Vision & Mission
    Driven by the philosophy of “Chemistry Connects the Future,” Changsha Wanwei strives to be a pioneering force in the global chemical sector. By bridging innovation, efficiency, and sustainability, we aim to build long-term partnerships that redefine industry standards and foster a greener, smarter chemical ecosystem.

    Global Reach, Local Expertise – Changsha Wanwei is your trusted partner for chemical excellence.

    Shop N-Ethyl-3-cyano-4-methyl-6-hydroxy-2-pyridone white powder-Detailed Image 4

    Shop N-Ethyl-3-cyano-4-methyl-6-hydroxy-2-pyridone white powder-Detailed Image 5

    Shop Wholesale good High Quality Pharmaceutical Material Antibiotic Drug CAS 64485-93-4 99% Purity API Powder Sterile Cefotaxime Sodium with Best Price-Detailed Image 5

    Shop Wholesale good High Quality Pharmaceutical Material Antibiotic Drug CAS 64485-93-4 99% Purity API Powder Sterile Cefotaxime Sodium with Best Price-Detailed Image 6


      Packaging & Shipping  


    Shop High Quality 2-Cyanophenol with CAS 611-20-1 for Organic Intermediate-Detailed Image 5


      Our Advantages  


    Shop Hydrochloride Intermediate 2-Cyanophenol CAS 611-20-1-Detailed Image 6


      FAQ  


    1.How to get in touch with us?

    You can chat with us by Trademanager,WhatsApp or simply giving us an email, a phone call. All our contacts information can be found from our website.

    2.Are you a manufacturer or trade company?

    We are a professional manufacturer.

    3.Can I get a sample?

    Yes, free sample can be provided, but shipping cost is covered by your side.

    4.What's your MOQ?

    It is based on the different product. Some are 1g while some are 1 kg. Please be free to consult our salesman.

    5.When can I get the quotation?
    We usually quote within 1 hours after we get your inquiry. If it's a urgent order you can call us or mention it in your email subject, and we can take it as priority.

    6.Is there any discount?
    Yes, some products are applied for discount, but it depends on the quantity.

    7.Can you do OEM for me?
    Yes,we accept OEM orders, just contact us and give us your requirement. We will offer you a reasonable price and make samples ASAP.

    Please feel free to contact us if you have any needs!

    Certificates
    • Wholesale good High Quality Pharmaceutical Material Antibiotic Drug CAS 64485-93-4 99% Purity API Powder Sterile Cefotaxime Sodium with Best Price Certificates 1

    Basic Info
    Product Name:

    Cefotaxime sodium

    Other Name:

    5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,3-[(acetyloxy)methyl]-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-8-oxo-,sodium salt (1:1),(6R,7R)-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,3-[(acetyloxy)methyl]-7-[[(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-,monosodium salt,[6R-[6α,7β(Z)]]-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,3-[(acetyloxy)methyl]-7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-,monosodium salt,(6R,7R)-;HR 756;RU 24756;Cefotaxime sodium salt;Cefotaxime sodium;(+)-Cefotaxime sodium salt;Tolycar;Sodium cefotaxime;Chemcef;Pretor;Cefotax;Oritaxim;Biotax;Cefantral;Novatax;Cefomerc;Sefagen;Clafora;Baxim;Biolog;Bioxim;CefSo;Cefacron;Cefcan;Cefomed;Cefomerk;Cefon;Cefotam;Cefoxim;Ceftim;Ceftop;Ceftoringe;Cefronate;Calcef;Claftax;Clavox;Califrid;Eaxiron;Elkotak;Epotazime;Evotaxime;Excef;Forax;Fortax;Zafixime

    CAS No.:

    64485-93-4

    Molecular Formula:

    C16H17N5O7S2.Na

    InChIKeys:

    InChIKey=UWNYOXHAYFLGIE-JUZDKLSSSA-N

    Molecular Weight:

    477.45

    EC Number:

    264-915-9

    HScode:

    29419000

    Categories:

    Antibiotics

    Characteristics
    PSA:

    229.88000

    XLogP3:

    -1.04720

    Appearance:

    white to yellow powder

    Density:

    1.8 g/cm3

    Melting Point:

    162-163 C

    Water Solubility:

    soluble in water.H2O: aqueous solutions of pH 4.3-6.2 are stable up to 3 weeks at 2-8 °C.soluble

    Storage Conditions:

    2-8°C

    Toxicity:

    Oral-rat LD50: > 20000 mg/kg; Oral-Mouse LD50: > 20000 mg/kg

    Flammability characteristics:

    Thermal decomposition releases toxic nitrogen oxides, sulfur oxides, sodium oxide fumes

    Specific rotation:

    D20 +55±2° (c = 0.8 in water)

    Hazard Identification

    Classification of the substance or mixture

    Skin sensitization, Category 1

    Respiratory sensitization, Category 1

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Danger

    Hazard statement(s)

    H317 May cause an allergic skin reaction

    H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled

    Precautionary statement(s)
    Prevention

    P261 Avoid breathing dust/fume/gas/mist/vapours/spray.

    P272 Contaminated work clothing should not be allowed out of the workplace.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    P284 [In case of inadequate ventilation] wear respiratory protection.

    Response

    P302+P352 IF ON SKIN: Wash with plenty of water/...

    P333+P317 If skin irritation or rash occurs: Get medical help.

    P321 Specific treatment (see ... on this label).

    P362+P364 Take off contaminated clothing and wash it before reuse.

    P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing.

    P342+P316 If experiencing respiratory symptoms: Get emergency medical help immediately.

    Storage

    none

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Tirzepatide,Retatrutide,Semaglutide

    Location:

    No. 2302, Changqing Road, Gaoyuan Community, Laodaohe Sub-district, Kaifu District, Changsha City, Hunan Province

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    10

    Total Annual Revenue:

    $10 million-$25 million

    Total Employees:

    101-200

    Year of Establishment:

    2023

    Changsha Wanwei Technology Co., Ltd. has been deeply engaged in the biopharmaceutical industry for over 20 years and stands as a global leader in the metabolic disease drug sector. Leveraging its integrated end-to-end capabilities covering "R&D, production, and commercialization" as well as profound industry expertise, the company firmly ranks among the top tier of the global biopharmaceutical industry. Its core products include multiple key varieties such as Semaglutide, Tirzepatide, Retatrutide, and Cagrilintide.​
    Eighty percent of the members in the company's core team possess over 15 years of experience in metabolic drug R&D. Many of them have led the launch of internationally blockbuster antidiabetic drugs. The team has successfully facilitated the approval of 12 innovative drugs, among which 5 have become top 50 best-selling prescription drugs globally. This has enabled the company to establish an irreplicable technical and experiential barrier in fields such as peptide drug molecular modification and long-acting formulation development.​
    On the R&D front, the company has built four national-level technology platforms, including peptide molecular design and oral formulation innovation, and holds more than 300 authorized patents. Its drug R&D cycle is 30% shorter than the industry average. On the production side, it owns the world's largest intelligent base for peptide drugs, with an annual production capacity of 500 kilograms. The base complies with the triple GMP standards of China, the United States, and the European Union, and achieves a 90% self-sufficiency rate in key raw materials, ensuring stable supply to over 120 countries. Additionally, the company has passed the unannounced inspections by the FDA (U.S. Food and Drug Administration) and EMA (European Medicines Agency) for 10 consecutive years.​
    Currently, Semaglutide has overcome the challenge of low oral bioavailability, achieving global sales of over 15 billion US dollars within 3 years of its launch. Tirzepatide surpassed 8 billion US dollars in sales in its first year on the market. Retatrutide has entered Phase III clinical trials, while the combination therapy of Cagrilintide is in Phase II clinical development. All these products demonstrate revolutionary therapeutic value. Looking ahead, the company will invest 25% of its annual revenue in R&D, focusing on the fields of metabolism and cardiovascular diseases, and is committed to becoming a global innovation benchmark in the biopharmaceutical industry.

  • Inquiry History
    3 Inquiries
    Country Product Purchase Quantity Date Posted
    Egypt

    Cefotaxime sodium, CEFOTAXIME SODIUM 98% white powder 64485-93-4 Senwayer

    5 KG May 27, 2024
    Egypt

    Cefotaxime Sodium

    10.00 KG Sep 20, 2023
    India

    CEFOTAXIME SODIUM

    105 KG Feb 5, 2025
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.